Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Reconnoitring newest Novelties and expertise in Industrial Biotechnology
- Industrial Biotechnology 2020

Report

We would like to extend our heart whelming thanks to all the wonderful keynotes, speakers, conference attendees, media partners, and guests for joining Industrial Biotechnology 2018.

AAC hosted the International Conference on Industrial Biotechnology and Bioprocessing during August 16-17, 2018 at Park Inn by Radisson Copenhagen Airport with the theme “Contribution of Industrial Biotechnology and Bioprocessing towards sustainable Bio economy”. Gracious response and active contribution were received from the Editorial Board Members of supporting International Journals as well as the Organizing Committee Members and keynote speakers along with the academic scientists, researchers, students who made this event happen.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Industrial Biotechnology | Green Chemicals | Synthetic Biology | Industrial Enzymes

Current research focus in Industrial Biotechnology | Agro Biotechnology | Biofuels and Biorefinery |Industrial Microbes

The conference was commenced with an opening ceremony followed by a series of lectures delivered by both honorable guests and members of the Keynote forum. The experts who astonished us with their wonderful presentations were:

Birgitte K Ahring | Washington State University | USA

Søren Kjærulff | FermBiotics | Denmark

Dongzhi Wei | East China University of Science and Technology | China

Christopher Sorensen | GreenLab Denmark | Denmark

Lars Haastrup Pedersen | Aalborg University | Denmark

Christensen K V | University of Southern Denmark | Denmark

Heimann K | Flinders University | Australia

With the completion of Industrial Biotechnology 2018, AAC is excited to announce the 2nd International Conference on Industrial Biotechnology and Bioprocessing at London, UK from March 20-21, 2019.

Welcome Message

After a huge success and blockbuster accomplishment of the “2nd International Conference on Industrial Biotechnology and Bioprocessing” on June 12-13, 2019 at Edinburgh, Scotland. We at the AAC group proudly announce the “3rd International Conference on Industrial Biotechnology and Bioprocessing” during the month of February 17-18, 2020.

We would like to honour and appreciate the Industrial Biotechnology 2019’s Keynote speakers, session speakers, session organizers, chairs of the session and all the attendees without whom the efficacious achievement of the event was not possible.

Through a series of plenary sessions, workshops and breakout sessions, Industrial Biotechnology 2020 will provide a rigorous review of novel therapies, bio-products as well as report on the very latest findings in industrial biotechnology and bioprocessing research.

AAC group extends a very warm welcome to the eminent speakers, biotechnologists, researchers, and all the symposiast around the world to join our forthcoming 3rd International Conference on Industrial Biotechnology and Bioprocessing on Feb 17-18, 2019 at Paris, France.  We would love to see you and learn more about your specialization and to explore more on “Reconnoitring newest Novelties and expertise in Industrial Biotechnology”


 


    


Sessions/Tracks

Session on: Industrial Biotechnology:

Industrial Biotechnology which is also known as “White biotechnology” is one of the most favorable processes/methods to control most of the serious issues of modern industry. Enzymes and micro-organisms are used to make products that are bio-based in sectors like chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. This session will include the recent advances and research which enables to use renewable raw materials and can contribute to lowering greenhouse gas emissions and stirring away from a petrochemical-based economy. 

Session on: Bioprocessing and Bioseparation

Bioprocessing is used as a very essential tool for the rapid conversion of bioproducts from the research laboratory to commercial products. And the aim of practising bioseparation is to cleanse molecules, cells, and parts of cells into purified fractions. This can be used to explore and to enhance the speed in the discovery of bioprocesses application for the manufacture at a scale of next-generation commodity of industrial biotechnology. This session will focus on the latest innovations and new techniques that will lead to biomanufacturing industries for a better circular bioeconomy. 

Session on: Cell and enzyme engineering:

The application of genetic engineering techniques to enzyme technology is the most exciting innovation over the last few years. The yield and kinetics of the enzyme, the ease of downstream processing and various safety aspects may be improved or altered to make the enzyme more efficient. It will help to determine the specific product and pathways for reactions to occur and to convert from some certain compounds into biotransformation.

Session on: Biobased products:

Bioproducts or bio-based products are products made with some constituent of biological or renewable materials. It involves all the processes, starting from raw material production through the processing stages to the synthesis of end products, in addition to research, development and commercialization processes. The developing bioeconomy offers the potential to contribute significantly to the overall economies across the world. Also, bio-based product research& development can offer economic, environmental and health benefits.

Session on: Biocatalysis and biotransformation:

Biocatalysis can be explained as the use of natural products like one or more enzymes or cells to speed up (or catalyze) chemical reactions. By switching to biocatalysis as the main technology for chemical production, it will lead to green, reduces pollution and cost, and help towards bioeconomy. Biocatalysis will help in increasing the ability to use enzymes to catalyze chemical reactions in
industrial biotechnology.

Session on: Biomaterials:

Biomaterials play an important role in the medicine industry today mainly in restoring function and facilitating wound healing for people after injury or disease. The recent advances of biomaterials combine medicinebiologyphysics, and chemistry, and more recent fields are from tissue engineering and materials scienceBiomaterials found their application in various fields like in dental applications, surgeryand drug delivery.

Session on: Bioenergy and Biorenewables:

Bioenergy and Biorenewables offer a solution for the production of renewable energy from biodegradable sources, such as wastes from municipal, food, agricultural and biomass. The report says that bioenergy constitutes the majority (65%) of the EU’srenewable energy mix. The use of biomass energy can minimize our greenhouse gas emissions it’s feedstocks can also help in making profits for the agricultural industry. 

Session on: Bioreactor design and scale-up:

Bioreactor designing plays a vital role in the functioning of bioprocess mainly for upstream processing. Design and choice of the proper bioreactors is influenced by the nature of cells, engineering conditions, as well as economic and ethical considerations. To commercialize the product from laboratory scale to industrial scale, scaling up of the bioreactor is very important. The success of the process hinges, to a limit, on ensuring the designing aspects in bioreactor and the operational procedures. 

Session on: Bioplastics and Biopolymers:

Plastic is very commonly used petroleum derivative in the world and report says that each year 200 million tons of plastic are utilized/consumed by the living beings on Earth. As a substitute the use of bioplastics is being encouraged, which is 100% biodegradable, equally flexible to plastics, and the usage of biopolymers are already becoming famous in cities of Europe and the United States for ecological reasons. Poly-hydroxyalkonates. 

Session on: Synthetic Biology:

The objective of synthetic biology is to make biology convenient to engineers. Synthetic biology is the mixture of innovations in biology and computer science that validate us to go from idea to product faster, cheaper, and with greater precision than ever before. It has applications in areas as diverse as industrial biotechnology, health, agro-industries and conserving ecosystems.

Session on: Regenerative Medicine and Tissue Engineering:

Hereby regenerative medicines we mean the bioprocess engineering area of stem cell tissue engineering including scale-up and scale-down. In the “whole bioprocessing” aspect, the complete process starting from a donor or patient biopsy through to clinical insertion into the patient. Regenerative medicine and tissue engineering are one of the fastest-growing area of research in industrial biotechnology. 

Session on: Agri-food technology:

The Agri-food industry has a significant role to play in industrial biotechnology, the motive of which is to feed populations, mostly through a chain of market relationships. The food system within the agri-food industry varies by country. Techniques like genetic engineeringmolecular markersmolecular diagnosticsvaccines, and tissue culture, is utilized by agricultural science to alter the genes in living organisms including plants, animals, and microorganisms.

Session on: Marine biotechnology:

Marine Biotechnology or blue economy is securing industrial products and processes by synthesizing proteins and enzymes and can also support new process innovation in the pharmaceutical and food industries or in molecular biology and diagnostic kits. The new applications of marine-derived enzymes are found to be in the beauty industry and the use of algae and microalgae in biofuel production.

Session on: Cell therapy bioprocessing:

Cell therapy bioprocessing activity is to make the research experts empower the safe, clinically useful and affordable production of cell therapies into commercial end products to be delivered to the patients. Current research is towards manufacturing new cell and bioprocess engineerintools to enhance the efficiency and techniques for health technology assessment to support the rapid clinical adoption of new cell therapies.

Session on: Algal Technologies:

Algae are the ‘green gold’ of the future bioeconomy as they became a valuable and sustainable feedstock for numerous industries contributing to the bio-sustainability. Their application varies from biofuels, food additives, animal feed, novel food, bioplastics, cosmetics, biofertilizers or CO2 utilization and many more. The market is rapidly expanding, and it is still not reached its full potential. Scientists are working on new technologies and cost optimization to scale up pilot projects to industrial production for a better green and clean future.

Session on: Bioremediation and Waste Treatment:

A treatment management system that uses natural organisms to remove or neutralize pollutants and convert into less toxic or non-toxic substances. For a successful and effective bioremediation, the system needs a correct balance of the favorable temperature and nutrient content. It is a cost-effective method when compared to other clean up techniques, as it does not need a great deal of equipment or labor.

Session on: New IB tools & technologies:

One of the most prominent sectors in the industrial world is “biotechnology”. Today, the focus is to improve the efficacy and robustness of microbial cell factories, suitable for industrial production of products in the health industry and others. Strain engineering is to be done to improve the existing either by mutagenesis or advanced targeted methods. If industrial biotechnology is used to its full potential, it would be the best tool towards a sustainable bioeconomy

Session on: Bioeconomy and Circular economy:

circular economy focuses to redefine growth, aiming at positive public benefits. It avails gradually decoupling economic activity from the consumption of finite resources and designing waste out of the system. Bioeconomy is understanding mechanisms and processes at the genetic and molecular levels and applying this understanding towards global sustainability.

Related:  Industrial BiotechnologyConferences | Industrial Biotechnology and bioprocessing Conferences | Biotechnology Meetings | Bioprocessing Events | Bioenergy Conference

Related Societies and Association:

Europe: Young European Biotech Network(YEBN), European Federation of Pharmaceutical Industries and Associations (EFPIA), European Bio-pharmaceutical enterprises (EBE), Biotechnology Industry Organization (BIO), European Association of PharmaBiotechnology (EAPB), DANSKBIOTEKDanish Biotechnology SocietyNovo Nordisk Foundation Center for Bio sustainabilityBio-Business and innovation platformIrish Bio-Industry Association (IBIA).

USA: Biotechnology Innovation Organization (BIO), Bioindustry AssociationSwiss Biotech AssociationMassachusetts Biotechnology CouncilAssociation of Biotechnology LedEnterprises (ABLE), Illinois Biotechnology InnovationOrganization (bio), Society for Industrial Microbiology and Biotechnology (SIMB).

Asia- Pacific: Asian Federation of biotechnology (AFOB), Federation of Asian Biotech Association (FABA), Bio-Asia

Market Analysis

USA: It’s been reported by Ernst & Young, that last year's sales of$13.4 billion and revenues of $18.6 billion is a lot more than the previous two decades’ figures. This year, the industry has recruited more than 153,000people in the United States. Last year, American biotechnology industries have invested $9.9 billion on R&D.

Asia-Pacific: The Asia-Pacific biotech market has expanded with a compound annual growth rate (CAGR) of around 16% during2010-2012. It has been found that Japan and China are controlling this industry, while countries like Malaysia, India, and Singapore are also in the limelight and are looking forward to dominating around 70% of the global market.


Europe: A prosperous bio-based European economy is mainly because of the industrial biotechnology sector and more than 60% of the world’s enzymes, has been produced, thus making Europe, a world leader in the industrial biotechnology
field. The major countries in the European Union that came up in this sector included Denmark, Germany, Netherlands, France, UK, and Sweden


Why France?

Industrial Biotechnology research in France is ranked third in the world. Earlier this month, France Biotech, which represents life science entrepreneurs, released its 16th“French HealthTech Survey,” which that showed the transformation of the French biotech environment over the past decade has grown to include more than 1,800 companies with abroad focus on multiple aspects of the healthcare space. According to the survey, France’s life science industry includes 720 biotech companies, 73biocleantech companies, 886 companies specialized in medical devices and diagnostics and 200 companies focusing on eHealth. The latest survey shows that more than half of these companies, 53 percent, employ one to 10 employees. Also, many of these companies have sprung into existence over the past several years. According to the survey, 41 percent of the companies are less than five years old.

Why Paris?

The capital city is a center for research in biotechnology as much as it is the hub for fashion. Being an impressive blend of both worlds, Paris offers a great platform to host biotechnology conferences owing to a large number of internationally applauded research institutes and universities. Its state-of-the-art laboratories covering all scientific disciplines makes Paris a very favorable destination for technical summits and conferences.


Growth of Biotech Industries in France

The figure for firms is a solitary method to rank industrial biotech by country, although disbursements in research and growth are additional. The United States outspends its adjoining competitor, France, by eight to one, at nearly $27 billion to a little over $3 billion in 2012. The other big payors are Switzerland, Korea, Japan, Germany, and Denmark at allover one billion dollars. France is growing rapidly in terms of biotech industries. A huge growth can be seen in the progress graph. You can see the growth in the following graph. 



Top biotech company in France:

  • NOVARTIS
  • SANOFI
  • PFIZER
  • MERCK & CO
  • MYLAN
  • ROCHE
  • SERVIER
  • GILEAD SCIENCES
  • JANSSEN-CILAG
  • ASTRAZENECA
  • GLAXOSMITHKLINE

Place of Attraction

Paris, also known as the “City ofLight” has enormous attractions to make your tour unforgettable. We are discussing top 8 places of attractions in Paris.


Eiffel Tower

     

The first thing that strikes your mindafter hearing Paris is The Eiffel Tower.

It was built by Gustave Eiffel tocelebrate the era of the French Uprisings. Height of this tower is 324 meters and it is among the most visited monuments in the world with every year approximately 7 million visitors.

The first floor is known as the EiffelTower 58 because of its height from the ground. The best sight can be seen fromthe second floor while diving. But the 3rd floor will surprise you with theamazing Gustave Eiffel’s office view.

The second most enduring place isNotre – dame de Paris, which is often known as Notre Dame. It is consideredglobally as one of the optimum instances of French Gothic architecture inEurope. The river Ile de la Cite increases the beauty of this cathedral.

Construction of the Notre Dame wasbegun in 1163 and was completed in 1345. This cathedral is a view with itsgateways surrounded by many sculptures and gargoyles that ornament the roof.


Louvre Museum


The most visited art museum in theworld resides in the heart of Paris. Louvre Museum is a former royal palacewith a boundary of approximately 210,000 square meters. This museum containsthe remains of the fortress that was built in the 12th century under the kingPhilip II.

Different departments of Louvre Museumare:-

  • ·         Egyptian antiquities
  • ·         Oriental antiquities
  • ·         Greek, Etruscan and Roman
  • ·         Islamic Art
  • ·         Sculptures of the Middle Ages,Renaissance and Modern Times
  • ·         Objects of art
  • ·         Paintings
  • ·         Graphic arts 

  

Arc of Triumph


Arc of Triumph was built in the 19thcentury dedicated to the glory of the imperial armies. This largest monumentwas commissioned by Napoleon. The pillars of the monument are garnished byastonishing sculptures.

On the top of the arc, names of 558Generals and the great victories of Romans are engraved. And Tomb of Unknownsoldiers can be seen under the Arc de Triomphe. A very beautiful view of Pariscan be observed upon the terrace of the door.


Cruise on the Seine


The “City ofLight” can be better visited by enjoying a cruise on the river Seine duringnight. After the sun set, all the monuments are lit slowly. A panoramic view tothe forefront is observed, therefore, you can feel the beauty of Paris i.e.,Eiffel Tower, Notre Dame, Pont Alexandre III and many more.


Montmarte


In theNorthern of Paris, a hill known as Montmartre is located which is 130 metershigh. This hill is best seen for the white-arched Basilica of the Sacred Heart,at the top.


Palaceof Versailles


One of the most famous castles inFrance is Palace of Versailles. It was built in the 17th century asa symbol of military power of France. This enormous complex of buildings, lawnsand patios is undeniably a must for any sightseer who will be captivated byexcellent accommodations, lavish embellishments, furniture and golden works ofReawakening art.


Moulin Rouge


The Moulin Rouge is a burlesque knownas the divine origin of the legendary French Cancan. Established at the base ofMontmartre hill in the soul of Pigalle, it was constructed in 1889 by JosephOller and Charles Zidler. Initially launched as a courtship dance, the cancanmade viable the birth of the burlesque, now present in many nations around theworld. Today, the Moulin Rouge is a sightseer charm, offering entertainment fortourists from across the globe.

Organizing Committee
OCM Member
John Kaweske
President
Bio Clean Energy
Denver, USA
OCM Member
jennifer A Littlechild
University of Exeter
Exeter, United Kingdom
OCM Member
Dr.Sergey Suchkov
Director, Center for Personalized Medicine and Professor,, Department of Pathology, Sechenov University,
Russian Academy of Sciences, Saratov
Moscow, Russia
OCM Member
Ashley Jackson
IBioIC – Industrial Biotechnology Innovation Centre
 Glasgow, United Kingdom
OCM Member
Ani Idris
Universiti Teknologi Malaysia
Kualalumpur, Malaysia
OCM Member
DR. Mohd Rafie Bin Johan
Nanotechnology & Catalysis Research Centre (NANOCAT), University Malaya
Kualalumpur, Malaysia
OCM Member
Dr. Dênis Pires de Lima
Federal University of Mato Grosso do Sul (UFMS)
Belo Horizonte, Brazil
OCM Member
Dr. Niranjan Koirala PhD.
PDF., Research Scientist University of Macau, Macau, Department of Civil and Environmental Engineering, Faculty of Science and Technology
University of Macau
Gungzhou, China
OCM Member
Dr. Farizul Hafiz Kasim
Dean of School of Bioprocess Engineering
Universiti Malaysia Perlis (UniMAP)
Kualalumpur, Malaysia
OCM Member
Professor Michael C. Flickinger
Dept. of Chemical & Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695, USA
North Carolina State University, USA
Raleigh, USA
OCM Member
Abbas Safarnejad
Khorasan Razavi Agricultural and Natural Resources Research Center
Babol, Iran
Renowned Speakers
Venue
&
Hospitality



Paris is the capital city of France. The city has an approximate area of 41 square miles with a population of 2,206,488 people as of 2018. Contrary to popular belief, the name of the city did not come from the Paris in Greek myths. Instead, the name Paris is derived from the city’s initial inhabitants who were part of the Celtic Parisii tribe. Sometimes, the city is called the City of Light for two reasons; it was among the first cities to adopt gas for lighting the streets and its role during the Age of Enlightenment.

One of the world’s most visited cities, Paris has something for everyone!!!

Gallery

Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
industrialbiotech@alliedforums.org
Sponsorship/Exhibitor
industrialbiotech@alliedgather.com
General Enquiry
industrialbiotech@alliedgather.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to industrialbiotech@alliedforums.org

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies Ltd postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writin industrialbiotech@alliedforums.org. Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

Before 60 days of the conference: Eligible for Full Refund less $100 service Fee

Within 60-30 days of Conference: Eligible for 50% of payment Refund

Within 30 days of Conference: Not eligible for Refund

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies Ltd will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

Highlights from last year's Convention

Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.